Loading...
XSHE002172
Market cap338mUSD
Jan 02, Last price  
3.23CNY
1D
3.19%
1Q
7.67%
Jan 2017
-68.43%
IPO
-73.63%
Name

Jiangsu Aoyang Health Industry Co Ltd

Chart & Performance

D1W1MN
XSHE:002172 chart
P/E
49.78
P/S
1.14
EPS
0.06
Div Yield, %
0.00%
Shrs. gr., 5y
-4.38%
Rev. gr., 5y
-14.33%
Revenues
2.17b
+7.54%
789,667,648985,574,1111,320,958,8122,087,321,4321,634,642,4282,340,465,8443,805,268,6453,823,992,5583,552,361,5403,277,439,6782,931,164,3883,808,778,5934,875,817,8335,366,490,3214,710,672,8762,982,034,9523,083,401,1793,028,918,8112,021,311,3172,173,767,566
Net income
50m
59,352,62158,002,34186,215,374216,937,5440161,105,804100,458,230035,652,82020,912,5310135,862,289259,242,227154,658,56610,359,785000049,681,623
CFO
54m
44,458,969240,863,00356,235,5520320,511,918184,258,82700544,264,366238,730,309494,924,498334,683,988555,087,08599,606,13200125,329,1790054,303,048
Dividend
Apr 17, 20080.15 CNY/sh
Earnings
May 16, 2025

Profile

Jiangsu Aoyang Health Industry Co.ltd. produces and sells chemical fibers in China and internationally. It offers various functional fibers, as well as conventional viscose fibers. The company also operates hospitals, rehabilitation centers, and pharmaceutical retail chains. In addition, it offers health management and pharmaceutical logistics, as well as distributes pharmaceutical products. The company was formerly known as Jiangsu Aoyang Technology Corporation Limited. and changed its name to Jiangsu Aoyang Health Industry Co.ltd. in September 2018. Jiangsu Aoyang Health Industry Co.ltd. was founded in 2001 and is based in Zhangjiagang, China.
URL
http://www.ayjk.cn/
IPO date
Sep 21, 2007
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,173,768
7.54%
2,021,311
-33.27%
Cost of revenue
1,980,615
1,828,742
Unusual Expense (Income)
NOPBT
193,153
192,569
NOPBT Margin
8.89%
9.53%
Operating Taxes
19,681
14,793
Tax Rate
10.19%
7.68%
NOPAT
173,472
177,776
Net income
49,682
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,093,429
1,316,477
Long-term debt
110,058
105,586
Deferred revenue
10,302
11,680
Other long-term liabilities
2,424
67,926
Net debt
495,227
421,279
Cash flow
Cash from operating activities
54,303
CAPEX
(63,595)
Cash from investing activities
(43,835)
896,523
Cash from financing activities
(11,428)
FCF
131,262
275,025
Balance
Cash
707,373
984,155
Long term investments
887
16,629
Excess cash
599,572
899,719
Stockholders' equity
(1,053,842)
919,243
Invested Capital
2,342,378
602,610
ROIC
11.78%
21.59%
ROCE
14.99%
12.82%
EV
Common stock shares outstanding
828,027
765,732
Price
3.79
-8.23%
4.13
2.48%
Market cap
3,138,223
-0.77%
3,162,475
2.48%
EV
3,633,449
3,583,753
EBITDA
265,582
268,799
EV/EBITDA
13.68
13.33
Interest
43,185
62,556
Interest/NOPBT
22.36%
32.48%